1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | 100.00% |
| Net profit | -6.69m | 3.21% |
| EBITDA | -6.62m | 2.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €3.52m |
Number of shares | 5.34m |
52-week high/low | €13.57 - €0.14 |
| Dividends | No |
Beta | 1.92 |
P/E ratio | -0.04 |
PEG ratio | 0.00 |
P/B ratio | 0.38 |
P/S ratio | 0.00 |
Company profile
| Name | Moleculin Biotech |
| CEO | Walter V. Klemp |
| Employees | 17 |
